LobbyingIonis Pharmaceuticals lobbying by quarter
Ionis Pharmaceuticals IONS's latest lobbying report covers Q2 2026, at $180K. The four quarters Q4 2025–Q3 2026 total $560K. Its first report covers Q3 2024; the issues it reports most are Health Issues and Medicare/Medicaid.
Ionis PharmaceuticalsIONS
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $560K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2024 | $100K | 2 |
| Q4 2024 | $100K | 2 |
| Q1 2025 | $110K | 2 |
| Q2 2025 | $110K | 2 |
| Q3 2025 | $200K | 2 |
| Q4 2025 | $200K | 2 |
| Q1 2026 | $180K | 2 |
| Q2 2026 | $180K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$566.7K · 16 reports
- Medicare and Medicaid$306.7K · 8 reports
- Taxation$306.7K · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES16 reports
- SENATE16 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseIonis Pharmaceuticals | $920K | 8 quarters |
| LMH Strategic Solutions | $260K | 8 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALANNA TEMME | Legislative Director, U.S. Representative Jon Porter | Q2 2026 |
| SOPHIE KHANAHMADI | Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions | Q1 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | In-house | $150K |
| 07/05for Q2 | LMH Strategic Solutions | $30K |
| 04/17for Q1 | LMH Strategic Solutions | $30K |
| 04/09for Q1 | In-house | $150K |
| 01/18for Q4 2025 | In-house | $140K |
| 01/12for Q4 2025 | LMH Strategic Solutions | $60K |
| 25/10/20for Q3 2025 | LMH Strategic Solutions | $60K |
| 25/10/15for Q3 2025 | In-house | $140K |
| 25/07/16for Q2 2025 | In-house | $90K |
| 25/07/15for Q2 2025 | LMH Strategic Solutions | $20K |
| 25/04/18for Q1 2025 | LMH Strategic Solutions | $20K |
| 25/04/16for Q1 2025 | In-house | $90K |
| 25/01/16for Q4 2024 | In-house | $80K |
| 25/01/08for Q4 2024 | LMH Strategic Solutions | $20K |
| 24/10/15for Q3 2024 | In-house | $80K |
| 24/10/09for Q3 2024 | LMH Strategic Solutions | $20K |
| 24/08/07for Q3 2024 | LMH Strategic Solutions | Under $5,000 |
| 24/08/07for Q3 2024 | In-house | Under $5,000 |